Document Type
Article
Publication Date
4-24-2026
Abstract
RAB12 is a small GTPase and a validated substrate of LRRK2, a kinase genetically linked to Parkinson's disease (PD). While RAB12-LRRK2 signaling has been implicated in ciliogenesis and immune regulation, the neuronal function of RAB12 remains largely unexplored. Here, we investigated the role of RAB12 in synaptic physiology using Rab12 knockout (KO) mice. Rab12 KO mice developed normally but exhibited increased locomotor activity in adulthood. Electrophysiological recordings from striatal slices revealed enhanced presynaptic release probability and increased excitatory drive onto medium spiny neurons. Consistently, live-cell imaging of cultured cortical neurons revealed that Rab12 deletion facilitated, while Rab12 overexpression inhibited, synaptic vesicle exocytosis. Biochemical fractionation showed enrichment of RAB12 in synaptic vesicle-associated fractions containing presynaptic components. Proteomic analysis of Rab12 KO striatal synaptosomes further identified alterations in proteins involved in synaptic membrane trafficking pathways. Together, these findings establish RAB12 as a negative regulator of synaptic vesicle exocytosis and excitatory neurotransmission in vivo. Our study defines a physiological role for RAB12 in synaptic function and provides a basis for future investigation into how LRRK2-dependent RAB12 signaling may contribute to neuronal dysfunction in PD.
Recommended Citation
Li, Xingjian; Chen, Yuanxin; Wang, Huaixing; Zhang, Xue; Guiberson, Noah Guy Lewis; Li, Xianting; Burré, Jacqueline; Peng, Junmin; Zhang, Hui; and Yue, Zhenyu, "Disruption of the LRRK2 Substrate RAB12 Facilitates Neurotransmission and Causes Hyperactivity in Mice" (2026). Department of Neuroscience Faculty Papers. Paper 96.
https://jdc.jefferson.edu/department_neuroscience/96
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 License.
Data S1.xls (6140 kB)
Data S2.xls (925 kB)
Data S3.xls (132 kB)
Data S4.xls (242 kB)
Data S5.xls (33 kB)
Data S6.xls (1158 kB)
Data S7.xls (168 kB)
Data S8.xls (260 kB)
Language
English

Comments
This article is the author's final published version in npj Parkinson's Disease, Volume 12, Issue 1, 2026, Article Number 159.
The published version is available at https://doi.org/10.1038/s41531-026-01353-4. Copyright © The Author(s) 2026.